About this trial
Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Must have a diagnosis or presumed diagnosis of bone or soft tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.)
Patient, or his/her designated power of attorney, must be able to understand and approve of the consent to participate.
Disqualifiers
Prisoners are excluded from participation in the Registry.
Trial population
Adult patients with a diagnosis of bone or soft-tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.)
Trial design
Cohort
Prospective
Treatments tested in this trial
Observation
Other intervention
Treatment groups
Trial outcomes
Primary outcomes
Overall Survival
Sponsors and contacts
Click on the lead sponsor to view all of their trials.